CRISPR Therapeutics AG (CRSP) closed the latest trading day at $41.22, indicating a +0.12% change from the previous session's end. This change outpaced the S&P 500's 0.08% gain on the day. On the ...

Cathie Wood’s ARK Invest is taking advantage of the recent dip in Tesla (TSLA) stock by purchasing 9,351 shares through its ARKK ETF (ARKK), ...

Zurcher Kantonalbank Zurich Cantonalbank raised its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 3.0% in ...

Farther Finance Advisors LLC boosted its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 34.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & ...

Cathie Wood’s ARK ETFs have published their daily trades for Wednesday, March 19th 2025, with a series of buys and sells across a range of innovative companies. Leading the purchases was a significant ...

We recently published a list of 12 Most Shorted Stocks in 2025. In this article, we are going to take a look at where CRISPR ...

We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on wallstreetbets Subreddit Page by MADD-Scientis. In this ...

Professor Bessembinder and his associates utilized security data from the Center for Research in Securities Prices (CRSP).

Additionally, the ARKK ETF and the ARK Genomic Revolution ETF (ARKG) bought a total of 105,974 CRISPR Therapeutics (CRSP) shares for $4.6 million and 80,975 GitLab (GTLB) shares for $4.27 million.

ARKK continues to underperform the market and, unfortunately, this does not mean that a reversal is coming. Read why I remain ...

Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options begin trading today, for the April 25th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. ZUG, Switzerland and BOSTON, Feb. 26, 2025 (GLOBE ...